[1]胡少丹,仕 丽△,孙 峰,等.助阳补肺除痹颗粒对肺纤维化大鼠肺组织超氧化物歧化酶活性、丙二醛含量影响的研究*[J].陕西中医,2019,(6):683-686.
　HU Shaodan,SHI Li,SUN Feng,et al.Effect of Zhuyang Bufei Chubi granule on superoxide dismutase activity and malondialdehyde content in lung tissue of rats with pulmonary fibrosis[J].,2019,(6):683-686.
点击复制

助阳补肺除痹颗粒对肺纤维化大鼠肺组织超氧化物歧化酶活性、丙二醛含量影响的研究*
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2019年6期
页码:
683-686
栏目:
基础研究
出版日期:
2019-06-05

文章信息/Info

Title:
Effect of Zhuyang Bufei Chubi granule on superoxide dismutase activity and malondialdehyde content in lung tissue of rats with pulmonary fibrosis
文章编号:
DOI:10.3969/j.issn.1000-7369.2019.06.001
作者:
胡少丹; 仕 丽△; 孙 峰; 刘守华; 杨 波; 匡 旭; 李菁婧
长春中医药大学附属医院肺病科（长春 130021）
Author(s):
HU Shaodan;  SHI Li;  SUN Feng;  et al.
Department of Pulmonary Disease, the Affiliated Hospital of Changchun University of Chinese Medicine（Changchun 130021）
关键词:
肺纤维化; 助阳补肺除痹颗粒; SOD活性; MDA含量; 动物实验; 大鼠
Keywords:
Key words Pulmonary fibrosis; Zhuyang Bufei Chubi granule; SOD activity; MDA content; Animal experiments; Rat
分类号:
R256.1
文献标志码:
A
摘要:
摘 要 目的：观察助阳补肺除痹颗粒对肺纤维化大鼠肺组织SOD活性、MDA含量的影响。方法：SPF级Wistar大鼠，按体重随机分为6组，每组30只动物。分别为假手术组、模型组、醋酸泼尼松组及助阳补肺除痹颗粒高、中、低组，采用博来霉素复制肺纤维化大鼠模型，假手术组大鼠以等量生理盐水代替盐酸博来霉素。各组大鼠自建模后第2天起每天灌胃给予相应药物1次，分别于造模后第7天、第14天和第28天给药后1h，每组随机选取10只动物，处死后剖取右侧肺组织，采用分光光度法检测肺组织SOD活力、MDA含量。结果：肺组织中SOD活性比较，假手术组高于模型组（ P <0.05），醋酸泼尼松组动物及助阳补肺除痹颗粒高剂量组均高于同期模型组（ P <0.05），助阳补肺除痹颗粒中剂量组、低剂量组在第28天时高于同期模型组（ P <0.05）。肺组织中MDA含量比较，假手术组低于模型组（ P <0.01），醋酸泼尼松组动物及助阳补肺除痹颗粒高剂量组低于同期模型组（ P <0.05），助阳补肺除痹颗粒中剂量组低于同期模型组（ P <0.05），低剂量组在第28天时低于同期模型组（ P <0.05）。结论：助阳补肺除痹颗粒能够通过增加肺组织中SOD活性，降低MDA的释放，抑制肺纤维化的进程。
Abstract:
Abstract Objective：To observe the effect of Zhuyang Bufei Chubi granule on SOD activity and MDA content in lung tissue of rats with pulmonary fibrosis. Methods：SPF Wistar rats were randomly divided into 6 groups according to body weight, 30 animals in each group were sham-operated group， model group. prednisone acetate group. The high, middle and low dose of Zhuyang Bufei Chubi granule group.The model of pulmonary fibrosis was induced by bleomycin. In the sham operated group, the equivalent saline was used to replace bleomycin hydrochloride. The rats in each group were given the corresponding drugs once a day from 2 day after modeling, after modeling 7th day, 14th day and the 28 th day respectively, 10 animals were randomly selected in each group. The right lung tissue was dissected and the SOD activity and MDA content in lung tissue were detected by spectrophotometry. Results：Compared with the model group, the SOD activity in the lung tissue of the sham operated group was higher than that of the model group ( P < 0.05). Prednisone acetate group and high dose group of Zhuyang Bufei Chubi granule were higher than the model group ( P <0.05).Middle dose group and low dose group on the 28 day was higher than that of the model group ( P <0.05). Compared with the model group, the MDA content in the sham operated group was lower than that in the model group ( P <0.01). Prednisone acetate group and high dose group were lower than model group ( P <0.05).Middle dose group was lower than the model group ( P <0.05), and the low dose group was lower than the model group on the 28 th day ( P <0.05). Conclusion：Zhuyang Bufei Chubi granule can increase SOD activity in lung tissue, decrease the release of MDA content and inhibit the process of pulmonary fibrosis.〖LM〗

参考文献/References:

[1] 陈 雁，王玉敏. 抗肺纤维化植物提取物的研究进展[J]. 中国老年学杂志,2018,38（1）:230-232.
[2]杨 晗，王 飞，杨 昆. 补阳还五汤对博来霉素所致肺纤维化大鼠肺组织ERK表达的影响[J]. 中华中医药杂志，2017,32（4）:1727-1730.
[3] 胡运勤.屏风生脉散联合强的松对气阴两虚型特发性肺纤维化患者疗效及T细胞亚群的影响[J].陕西中医，2017，38(7)：114-118.
[4] Huang H,Peng X,Nakajima J.Adranus in the study of biomarkers of idiopathic pulmonary fibrosis in Japan[J].Biosci Trends,2013,7(4):172-177.
[5] Borensztajn K,Crestani B,Kolb M, et al .Idiopathic pulmonary fibrosis:from epithelial injury to biomarkers-insights from the bench side[J].Respiration,2013,86:441-452.
[6] 钱张帅，邓家刚，黄思诗，等.中药治疗肺纤维化的研究进展[J].医药导报，2014，33（9）:1208-1211.
[7] 杨 宁,崔轶霞,张彩莲.老年慢性阻塞性肺疾病合并肺间质纤维化40例临床分析[J].陕西医学杂志，2015，44(10):1147-1150.
[8] 滑 振,吕晓东,庞立健,等.间质性肺疾病中医证素辨证规律及特点的临床研究[J].陕西中医，2015，36(8):657-660.
[9] 李 猛,李耀辉,马战平.肺间质纤维化中医诊治思路探析[J].陕西中医，2014，35(8)：621-624.〖ZK)〗
[10] 刘 锐,叶传冬,雷宁宁.中药治疗特发性肺纤维化的临床研究近况[J].国际中医中药杂志，2017，35(6)：224-227.
[11] 王 檀，赵东凯.助阳补肺除痹颗粒治疗间质肺疾病40例临床观察[J].中国卫生标准管理，2015，6（15）:156-157.
[12] 赵东凯，杨桂仙.助阳通痹法联合肺康复治疗间质性肺疾病30例临床观察及运动耐量改善情况评价[J].中国中医药现代远程教育，2017，15（22）:89-90.
[13] 袁成波，王 檀.助阳补肺除痹颗粒治疗间质性肺疾病脾肾阳虚，肺络痹阻60例临床观察[J].医学综述，2016，20（9）:199-20.
[14] 邵景韫,刘 安,杜旭升,等.肺间质纤维化患者的PAI-1、VEGF的变化[J].陕西医学杂志，2016，45(8)：887-890.
[15] 刘耸峰,吕晓东,庞立健,等.基于聚类分析探究中药复方治疗肺间质纤维化临床用药规律[J].世界中医药，2016,30(7):105-108.

相似文献/References:

[1]杭 程,肖 洋,王高雷,等.米烈汉教授基于宗气为本防治肺纤维化经验浅析[J].陕西中医,2021,(9):1282.[doi:DOI:10.3969/j.issn.1000-7369.2020.09.036]
[2]李世霞,张旭辉,李红梅,等.肺纤维化中内质网应激作用机制及中医药防治研究进展[J].陕西中医,2023,(12):1819.[doi:DOI:10.3969/j.issn.1000-7369.2023.12.034]
[3]邓祥丽,陈丽娟,邵 梅,等.益肺汤调控TGF-β1/Smad2通路抗肺纤维化机制研究[J].陕西中医,2024,(4):435.[doi:DOI:10.3969/j.issn.1000-7369.2024.04.001]
　DENG Xiangli,CHEN Lijuan,SHAO Mei,et al.Mechanism of Yifei decoction regulating TGF-β1/Smad2 signaling pathway against pulmonary fibrosis[J].,2024,(6):435.[doi:DOI:10.3969/j.issn.1000-7369.2024.04.001]

备注/Memo

备注/Memo:
*吉林省科技厅自然科学基金资助项目（20180101115JC） 吉林省科技厅科技攻关计划项目（20150204045YY）
更新日期/Last Update: 2019-06-20